News Releases
Herpes Virus Treats Head And Neck Cancer Patients
30 July 2010
A genetically engineered cold sore virus has been used to treat head and neck cancer patients in a Phase I/II clinical trial run by The Institute of Cancer Research (ICR) and The Royal Marsden NHS Foundation Trust.
Read more...
The Institute of Cancer Research Chief Executive to Become Deputy Chairman of the Wellcome Trust
23 July 2010
The Institute of Cancer Research’s Chief Executive Professor Peter Rigby has been named the next Deputy Chairman of the Wellcome Trust’s Board of Governors. He will take up the position at the independent, global biomedical charity in October.
Read more...
Therapy Reduces Dangerous Side-effects of Cancer Treatment in Children
20 July 2010
Children given a hormone growth factor alongside chemotherapy for the aggressive cancer neuroblastoma are less likely to suffer a potentially deadly side-effect, according to a major international study published today in the Journal of Clinical Oncology*.
Read more...
Gene Study Backs Promise of Breast Cancer Drugs to Treat Hereditary Prostate Cancer
25 June 2010
The way prostate cancer develops in men who have an altered ‘breast cancer gene’ is the same route by which breast cancer develops in women with the same mutation, reveals a study published in PLoS Genetics
Read more...
Pioneering Cancer Centres Launch New Academic Partnership
22 June 2010
A new academic partnership will be officially launched next week when Mount Vernon Cancer Centre joins the long-standing collaboration between The Royal Marsden and The Institute of Cancer Research (ICR).
Read more...
Scientists Identify Three New Genetic Variants that Increase Testicular Cancer Risk
13 June 2010
A study led by The Institute of Cancer Research (ICR) has identified three new genetic risk factors for testicular cancer. The findings, published online today in Nature Genetics, come during the Everyman Male Cancer Awareness Month, which aims to increase awareness and funding for vital research into testicular and prostate cancers.
Read more...
Long-term Side-effects of Testicular Cancer Chemotherapy
9 June 2010
Long-term side-effects including nerve pain, hearing loss and discoloured fingers and toes are a risk for men given chemotherapy treatment for testicular cancer, new research shows. The study in the journal Cancer provides strong evidence that doctors should give men the minimum amount of treatment required to cure their disease.
Read more...
Genetic Mutation Confirmed as Melanoma Drug Target
9 June 2010
A mutation present in around half of malignant melanomas has been confirmed as a strong drug target, according to research published today in Science Translation Medicine. The study was conducted by The Institute of Cancer Research (ICR) and funded by the Wellcome Trust, Cancer Research UK and the ICR.
Read more...
Cancer Drug Researcher Receives Royal Society of Chemistry Award
4 June 2010
Professor Paul Workman from The Institute of Cancer Research (ICR) has received a prestigious award from the Royal Society of Chemistry for his work in discovering exciting new anti-cancer drugs.
Read more...
Genetic Mutation Shown to Trigger Melanoma
1 June 2010
Researchers have discovered that a genetic mutation found in some malignant melanomas can initiate development of this most deadly form of skin cancer, according to a study published today in the journal Cancer Research.
Read more...
